A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. - Wikidata - wikimedia - TriplyDB

A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.

A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.

http://www.wikidata.org/entity/Q39185534

about

Breast Cancer Cell Invasion into a Three Dimensional Tumor-Stroma Microenvironment.Living Cell Microarrays: An Overview of Concepts Identification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance Spectrometry β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids Novel three-dimensional in vitro models of ovarian endometriosis.SOX2 is required to maintain cancer stem cells in ovarian cancer.Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination Spherical cancer models in tumor biology.Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma.Three-dimensional modeling of ovarian cancer.Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer.A method to investigate the anti-metabolic activity of anti-cancer agents on ovarian cancer cells cultured in a 96-well high throughput format Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1).The characteristics of Ishikawa endometrial cancer cells are modified by substrate topography with cell-like features and the polymer surface Resveratrol, Acetyl-Resveratrol, and Polydatin Exhibit Antigrowth Activity against 3D Cell Aggregates of the SKOV-3 and OVCAR-8 Ovarian Cancer Cell Lines.Advantages of the avian model for human ovarian cancer Biomaterials and emerging anticancer therapeutics: engineering the microenvironment.Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress.Liquid-based three-dimensional tumor models for cancer research and drug discovery.Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms.Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer.Targeting Src in endometriosis-associated ovarian cancer Neighborhood matters: response to EZH2 methyltransferase inhibitors.Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells.Bioprinting the Cancer Microenvironment.Culture models to define key mediators of cancer matrix remodeling.Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment.Proton NMR characterization of intact primary and metastatic melanoma cells in 2D & 3D cultures.3D tumor models: history, advances and future perspectives.Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo.Receptor-targeted drug delivery: current perspective and challenges.Hydrogels for 3D mammalian cell culture: a starting guide for laboratory practice.Chemical analysis of multicellular tumour spheroids.Three-dimensional patterning in biomedicine: Importance and applications in neuropharmacology.Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells.Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.Protein Expression Differences of 2-Dimensional and Progressive 3-Dimensional Cell Cultures of Non-Small-Cell-Lung-Cancer Cell Line H460.Human Brain Malignant Glioma (BMG-1) 3D Aggregate Morphology and Screening for Cytotoxicity and Anti-Proliferative Effects.Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells.

P2860

Q27342933-880CB48E-06FE-42C0-A051-D76642E5EF54 Q28073823-B55C462A-D06A-44F1-8F15-B98C33C92ED8 Q28553966-2090D5D0-920A-4242-B0E8-9F2A169C4BC1 Q30370274-B6B2EF74-41F4-468E-9E47-979FF43BC4D9 Q33589839-D1229F3A-1FCA-423E-A8F4-77A35BF15498 Q33607622-FC9EEB93-987F-41C5-90B0-0E4ADB9FB9A2 Q33641924-D8A7E9FA-95DD-4801-8A5C-711ED6E25DD1 Q33872469-C8BA3DC9-7053-4637-B2BB-C972F5BA3320 Q35023931-3A5DE6A2-F871-4E7D-A0F0-3A4DA41CA362 Q35116051-CC839F62-A652-4575-A09E-4B105B2859C9 Q35591610-3011D360-915A-4118-B82B-516E5557E85D Q35666119-B5F1B8AB-9CBD-4D58-84C8-28E1346F7C61 Q35817502-EBD572B0-1A26-47DF-8649-39D18C2218F1 Q35837125-A968FCC2-B4C9-4F0D-9248-255A0ADEB789 Q35935059-4E1656B3-4F37-4BF4-8B0D-B0B2AF214873 Q36296708-4F85E8CF-9C20-4CB0-A9D3-DEBD1450E68D Q36334681-BEEEFCC3-29C9-4BA3-B8CF-9A48D0DFD97B Q36684345-0E164004-C04B-4940-A725-6F07E99F81F1 Q36953366-0800FC3E-9153-4FCF-AB2F-E0F007C78BF3 Q37107139-D7A3F5BF-F768-43AC-BB82-45CF2B790EED Q37119791-E998F7F6-D342-4658-A18E-253FA8E19A64 Q37197458-09FD38DF-E045-41C9-82FB-6F4B323238FB Q37224282-B14C8F2F-BAB1-403A-BCF6-003067A9A37A Q37344761-4E956599-9EE6-4054-8F0E-90131B22E3F2 Q37609400-AF3991B5-6C4F-4B03-850A-3397A84DA1B9 Q37670051-0EB2FFE3-D15F-49B0-9CF4-61272B5108F7 Q37676502-E53E7E27-839A-4206-A110-A9AAAAF33E44 Q37702160-8F8DD8C5-FE57-42AD-AA66-A677F0A87E9A Q37704991-D729EF0D-C921-49CD-BACC-7AD55E7201AC Q38221694-3E77A5F9-E00A-4A28-BE5C-9D62E16B5D1B Q38244951-C478F0CD-BFDC-48FE-B27F-E0986D91567E Q38265617-5B1664CC-1464-4BEA-9233-D5F695339450 Q38272482-5C81E32A-D0FC-4DD5-92C2-19E2561BABC1 Q38448942-FA2C7B8A-B769-4026-8C89-9C43B395A6BD Q38674847-55BA7A25-69A6-4DC2-9AC5-302DE85B9AA5 Q38703674-35DCE7C8-A5FE-47B6-AA7B-3B86167A0E28 Q38703766-49B0ABDA-8ECF-4382-ACF3-2E6CE5F4E3E2 Q38730500-7D262680-6126-4D4D-AF71-69063BE402FD Q38745830-9874284C-8B65-4631-BE51-408145D01550 Q38756515-F0C5A037-82CF-445B-ACAD-44723D86C76B

P2860

A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.

http://www.wikidata.org/entity/Q39185534

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

A three-dimensional microenvir ...... ovarian cancer cells in vitro.

@en

A three-dimensional microenvir ...... ovarian cancer cells in vitro.

@nl

type

label

A three-dimensional microenvir ...... ovarian cancer cells in vitro.

@en

A three-dimensional microenvir ...... ovarian cancer cells in vitro.

@nl

prefLabel

A three-dimensional microenvir ...... ovarian cancer cells in vitro.

@en

A three-dimensional microenvir ...... ovarian cancer cells in vitro.

@nl

P1433

Q39185534-FA8A308A-1565-4EF6-A975-431AE4B0C7E1

P1476

Q39185534-9251F1AA-B39D-4A09-8976-222FB45ABB5C

P2093

Q39185534-1E903221-37A3-4F3D-88F3-699CCEEAA92B

Q39185534-69354F73-0351-4B04-9F4C-0F405B429143

Q39185534-926D1F09-518D-4D1D-A60B-0E69E49B58B2

Q39185534-9B3DD31C-6D7E-4207-BF9A-C8595D7497E9

Q39185534-BBA6989D-C866-4529-8BA5-0D806B1A749B

Q39185534-E2D3E417-7076-4930-8920-8798CB8C6257

Q39185534-F2559F48-2026-433A-BE3B-F74BD1A94643

P2860

Q39185534-02CFCC37-A410-4DD9-B571-A6D53DC7A858

Q39185534-0AC59309-1CDB-4850-B748-CF70787FE996

Q39185534-0E1B7CBF-C2C0-43E0-AC0E-A5D31D6BC049

Q39185534-0FB10E8A-60D8-429E-9441-B28DC76E70C9

Q39185534-22B47672-D1E1-49F9-AE53-81DA68DA1994

Q39185534-28C1BA3D-2A6C-4437-AD87-3321BCB51AB3

Q39185534-29280498-AA19-4746-AFF8-08655B8EA8A6

Q39185534-2EF51D72-6C84-4186-AB24-C9CE9177C2A0

Q39185534-3410B9E7-5D9F-4F49-9597-1EE52381ECCB

Q39185534-3610B60E-F226-4DA2-BE28-561F6B31456F

P2888

Q39185534-1018F222-9889-4182-B3B0-16BD19771647

P304

Q39185534-59BD2315-B53C-400A-8860-3B9A77BF53FA

P31

Q39185534-8DB1485B-2E9A-401C-AF6A-CA30F4E80815

P356

Q39185534-8151E6C0-4476-47A3-B97D-8612D3FF37B7

P433

Q39185534-F21018A7-D4D4-4843-999A-9D639D2E4DB5

P478

Q39185534-1C427843-4B16-4617-850F-194E852FA957

P577

Q39185534-F0C92F78-C20E-4801-BA96-3F4038FB8FDE

P5875

Q39185534-712CC4FF-BA1E-45F4-8DE6-7773F112567D

P698

Q39185534-6BBEB401-9381-42BA-946E-30982E06E593

P921

Q39185534-2D3C3444-DC0E-41D2-9C92-D773347322A9

P356

LABINVEST.2013.41

P1433

Laboratory Investigation

P1476

A three-dimensional microenvir ...... ovarian cancer cells in vitro.

@en

P2093

Janet Myungjin Lee

http://www.w3.org/2001/XMLSchema#string

Kate Lawrenson

http://www.w3.org/2001/XMLSchema#string

Lucineh Cristina Parsanian

http://www.w3.org/2001/XMLSchema#string

Nathan Lee

http://www.w3.org/2001/XMLSchema#string

Paulette Mhawech-Fauceglia

http://www.w3.org/2001/XMLSchema#string

Simon Andrew Gayther

http://www.w3.org/2001/XMLSchema#string

Yvonne Gail Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

Reactivity of a monoclonal antibody with human ovarian carcinoma

Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Spheroid-based drug screen: considerations and practical approach

Ovarian cancer spheroids use myosin-generated force to clear the mesothelium

Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation.

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer.

Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion

Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.

P2888

labinvest.2013.41

P304

528-542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.2013.41

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235786662

http://www.w3.org/2001/XMLSchema#string

P698

23459371

http://www.w3.org/2001/XMLSchema#string

P921